The Carlyle Group Invests in MAK-SYSTEM

InVita Healthcare Technologies Acquires MAK-SYSTEM

July 8, 2026

Healthcare Services

InVita Healthcare Technologies, backed by Novacap, completed its acquisition of MAK-SYSTEM to expand end-to-end blood management software solutions worldwide. The combined platform is intended to create a more connected and intelligent blood management ecosystem across donor to patient, improving visibility, interoperability, efficiency, and compliance.

Carlyle acquires majority stake in MAI Capital Management

March 31, 2026

Financial Services

Carlyle has agreed to acquire a majority stake in Cleveland-based registered investment adviser MAI Capital Management, valuing the firm at more than $2.8 billion. The transaction deepens Carlyle’s involvement in MAI following its initial 2021 investment via Galway Holdings, with Galway Holdings, Harvest Partners, and Oak Hill Capital exiting. The deal closed effective June 4, 2026, with MAI employees retaining a large minority stake and MAI continuing to operate autonomously under its leadership team.

Carlyle Acquires Majority Stake in Incubeta

November 16, 2022

Marketing & Advertising

The Carlyle Group, via its Carlyle Europe Technology Partners platform, has agreed to acquire a majority stake in Incubeta, a London-headquartered digital marketing and ad-tech agency. Carlyle will support Incubeta's international growth, investments in proprietary technology and commercial operations, and M&A-led market consolidation; terms were not disclosed.

Carlyle Leads Majority Growth Investment in Saama Technologies

October 20, 2021

AI & Machine Learning

Global investment firm Carlyle led a strategic growth investment of up to $430 million to acquire a majority stake in Saama Technologies. A syndicate of healthcare-focused investors — including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners — will co-invest to accelerate Saama's AI-driven Life Science Analytics Cloud and expand go-to-market and R&D capabilities.

The Carlyle Group and Mubadala Take Minority Stakes in Apex Group Ltd.

July 15, 2021

Financial Services

Apex Group Ltd. secured minority equity investments from The Carlyle Group and Mubadala Investment Company alongside founder Peter Hughes and existing investors Genstar Capital and TA Associates. The capital supports Apex's continued organic growth and integration of recent acquisitions as it expands its global fund and asset servicing platform; financial terms were not disclosed.

The Carlyle Group Makes Growth Investment in Pharmapacks

November 12, 2020

E-Commerce

The Carlyle Group made a strategic growth investment of more than $250 million in Pharmapacks, an ecommerce marketplace enablement platform and large marketplace seller, valuing the company at approximately $1.1 billion. The capital is intended to accelerate Pharmapacks' growth by expanding fulfillment capacity, building out its data and analytics platform, and increasing the number of brand partners; J.P. Morgan served as lender and advisor on the transaction.